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Abstract 
Background: The introduction of the dengue virus (DENV) in Nepal is recent, first reports date back to 2004 from a 
Japanese traveller and limited information is available about DENV infection in the Nepali population. Within a decade 
after the first DENV detection, it is now endemic in multiple districts of Nepal with approximately 11.2 million people 
residing in the Terai belt being at risk of DENV infection. Sporadic cases of DENV infection have been reported every 
year for the past decade during the monsoon season, mainly in the Terai region.
Methods: Medline/Embase/Cochrane databases were reviewed for reports on the burden of dengue infection, diag-
nostic methods, and national surveillance.
Results: Four outbreaks were reported since 2004 including the diagnosis of all serotypes in 2006 and predominance 
of a single serotype in 2010 (DENV-1), 2013 (DENV-2), and 2016 (DENV-1). The clinical diagnoses showed a predomi-
nance of dengue fever while 4/917 (0.4%), 8/642 (1.2%) and 8/1615 (0.4%) dengue haemorrhagic fever/dengue shock 
syndrome cases were identified during the outbreaks in 2010, 2013 and 2016, respectively. The number of cases 
reported in males was significantly higher (67.4%) than in females. Disease occurrence was primarily found in the Terai 
region until 2010 and was increasingly detected in the Hilly region in 2016.
Conclusion: In Nepal currently weak diagnostic facilities, very limited research on mosquitoes vectors, and poor sur-
veillance of dengue leading to inappropriate detection and control of DENV. We surmise that improved basic research 
and epidemiological training courses for local scientists and laboratory personal at national and international level will 
help better understand the evolution and distribution of DENV transmission and its eventual control.
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Background
The first record of a clinically dengue like disease was 
recorded in the Chinese medical encyclopaedia from 
the Jin Dynasty (265–420 AD) [1]. It was referred to as 
“water poison” associated with flying insects at that 
time [2]. Civilization and human migration contributed 
to the spread of dengue and its primary vectors, Aedes 
aegypti and Aedes albopictus, to new geographical areas 
[3]. A large epidemic of dengue was seen in different cit-
ies of Japan during WWII, including Nagasaki, Kobe, 
and Osaka [4] with 200,000 dengue cases in the years 
1942–1948 [5]. It seems the dengue virus infections origi-
nated from travellers who were returning from Southeast 
Asia and the Pacific islands [6]. Dengue was first recog-
nized in Manila, the Philippines in 1953 [7]. Viruses simi-
lar to DENV-1 and DENV-2 were isolated from Manila 
patients by William Hammond and were called DENV-3 
and DENV-4 in 1956 [8]. Similarly, Dengue viruses with 
multiple serotypes were isolated from patients of a den-
gue haemorrhagic fever (DHF) outbreak in Bangkok, 
Thailand in 1958 [9], and dengue outbreaks were mainly 
reported from Southeast Asia till the early 1980s [10].
Similarly, epidemiology of dengue in India is 
extremely complex and changing. The first reported 
occurrence of dengue fever dated to 1946, and no 
outbreaks were reported for almost 20  years until an 
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epidemic occurred in Kolkata in 1963–1964 [11]. In 
Delhi, the first major outbreak of dengue fever/den-
gue haemorrhagic fever (DF/DHF) occurred in Delhi 
in 1996, after three decades of very low incidence, with 
10,252 cases and 423 deaths [12]. India reported 28,292 
cases and 110 deaths in 2010 which is the highest num-
ber of cases and number deaths in a single year in the 
country in the previous two decades [13]. Co‐circula-
tion of multiple dengue virus serotypes and has been 
seen in Uttar Pradesh and Kerala, India during the last 
decade [14, 15].
Nepal is a landlocked Himalayan country bordering 
India in the East, West, and South and China’s auton-
omous Tibet region in the North. The population of 
Nepal is 26,494,504 (2011 census) [16]. The country is 
divided into three ecological regions (Terai, Hilly and 
Mountain Regions) and 75 districts. The population is 
unevenly distributed in these three ecological regions. 
The population is unevenly distributed, with 48.4% of 
the Nepalese populous residing in the Terai region and 
the remaining in the Hill and Mountain regions. Each 
district has one district hospital (government public 
hospital), and numerous private/non-governmental 
hospitals, nursing homes and medical colleges. The 
public hospitals commonly have their own laboratory 
for routine diagnosis which lacks a molecular labora-
tory for the confirmation of pathogens. The other pri-
vate hospitals rarely have molecular diagnosis and if so, 
it is very costly.
Although the Nepalese culture and daily lifestyle 
largely resembles that of India, dengue fever was not 
diagnosed for > 50  years while India already routinely 
reported cases. Here, we provide an overview of the 
epidemiology of dengue fever in three different Nepa-
lese regions and suggest local laboratory infrastruc-
ture improvements, particularly for the Terai region to 
ensure appropriate diagnosis and surveillance.
Methods
We searched the databases Medline/Embase/Cochrane 
for scientific literature published in the past 10 years for 
relevant evidence on the burden of dengue infection, 
diagnostic methods, and surveillance strategies/activities 
and discussed current gaps in diagnosis and surveillance 
in Nepal. The following search terms were used “dengue”, 
“diagnosis”, “epidemiology”, “Nepal”.
Dengue virus detection and epidemic pattern in Nepal
Sparse information on DENV infection in Nepal was 
available prior to 2004 [17], which changed with the 
report of one Japanese foreigner being diagnosed with 
dengue fever in 2004 [18]. Since then, four DENV out-
breaks occurred in Nepal, with the first endogenous den-
gue outbreak in the Chitwan district dating to 2006 [19]. 
At that time, the circulation of all four DENV serotypes 
was found in nine districts of the low-land Terai region 
[20]. Although the circulation of all four serotypes was 
reported during 2006–2007 dengue outbreaks, dengue 
serotype-1 (DENV-1) strains, closely related to Indian 
strains, were exclusively identified in the second outbreak 
in 2010 [21]. Similarly, only dengue serotype 2 (DENV-2) 
was identified during the third outbreak in 2013 [22, 23]. 
The Epidemiology and Disease Control Division (EDCD) 
from the Nepalese Ministry of Health documented 1615 
dengue cases in 32 districts (out of 75 districts) dur-
ing the fourth outbreak in 2016, predominantly DENV-
1, with the disease even reaching into the highlands 
(Table 1) where most of the cases reported were dengue 
fever while 4/917 (0.4%), 8/642 (1.2%) and 8/1615 (0.4%) 
DHF/DSS cases were reported during 2010, 2013 and 
2016 outbreak, respectively [24]. Similarly, the number 
of cases reported in males (n = 2248) was significantly 
higher than in females (n = 1086) i.e. 67.4% [24]. This 
might be because males have a higher vector exposure 
due to their predominance in outdoor work, especially 
Table 1 Circulation of dengue serotypes in Nepal
Years No. of sample 
tested
DENV serotype Percentage of dominant 
serotype
Epidemic/non-epidemic References
2004 32 2 100% Non-epidemic Takasaki et al. [18]
2006 276 1, 2, 3, 4 25% Non-epidemic Malla et al. [26]
2007 100 Not studied NA Non-epidemic Dumre et al. [28]
2008 25 Not Studied NA Non-epidemic Dumre et al. [28]
2009 35 Not studied NA Non-epidemic Dumre et al. [28]
2010 1215 1 100% Epidemic Pandey et al. [23]
2013 2340 2 100% Epidemic Gupta et al. [22]
2014 576 2 100% Non-epidemic Acharya et al. [20]
2015 545 Not studied NA Non-epidemic Gupta et al. [24]
2016 4125 1 100% Epidemic Gupta et al. [25]
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in fields and forests. Overall, the majority [1836/3334 
(55.1%)] of the dengue infections occurred in adults aged 
15–40  years which may be associated with the lack of 
immunity in this age group living in areas where dengue 
was recently reported [22]. The proportion of laboratory 
confirmed cases (n = 3634) among clinically diagnosed 
cases (10,966) is about 30% [25]. Dengue outbreaks were 
mainly diagnosed during the monsoon and post-mon-
soon periods, with a peak from August to October.
Geographically, dengue was first reported in Hilly 
region in 2010, and there are no reports of dengue cases 
from Mountain region published as of today (Fig.  1). 
There is an increasing trend of dengue in the Terai region 
potentially becoming a major public health concern, 
where it occurred at sporadic and/or epidemic rates with 
approximately 11.2 million residents at risk of DENV 
infection. Currently, due to the lacking laboratory equip-
ment in government hospitals RDT kits (SD Bioline Den-
gue Duo) are only provided during the occurrence of 
an outbreak and are missing for dengue diagnostic on a 
regular basis despite the increasing disease burden dur-
ing the last decade (Table 2).
Discussion
DENV infection is endemic in Nepal with outbreaks 
every 3 years since the first endogenous dengue detec-
tion in Nepal [23]. All four serotypes are circulating as 
sporadic cases throughout the year; however, a specific 
single serotype was found predominantly responsible 
for outbreaks that occurred after 2010 in the past [26]. 
A serotype-shift occurred over the years with a pre-
dominance of DENV-1in 2010, DENV-2 in 2013 and 
again DENV-1 in 2016 [25].
The dengue burden in Nepal is exacerbated by the 
open border between Nepal and India, poor availabil-
ity of medical and diagnostic facilities; inadequate mos-
quito control and the climatic conditions that favour 
vector expansion in the Nepal. DENV infection in 
Nepal is more common in the Terai region compared 
to the Hilly and Himalayan region presumably due to 
Fig. 1 Distribution of dengue cases from 2006 to 2016 in Nepal
Table 2 Health care facilities and dengue affected districts in Nepal
Region Districts Number of districts 
hospital
Number of molecular diagnosis 
laboratory in government hospitals
Dengue reported 
districts
Number 
of dengue case
Terai 20 20 NA 19 1473
Hilly 39 39 NA 13 46
Mountain 16 16 NA Nil Nil
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its ideal vector environment and the porous border 
between India and Nepal [27]. The vector has adapted 
to the extremes of warm and cold weather resulting in 
the occurrence of dengue cases throughout the year in 
Nepal.
In the past separate virus laboratories for the diagno-
sis of viral diseases were lacking in Nepal. Nowadays, 
laboratories that provide reliable confirmation of dengue 
infection are few and are based in Kathmandu, the capi-
tal city of Nepal. However, the majority of the population 
and specifically those at risk have no access to these facil-
ities. Recently diagnosis by commercial kits is available to 
many hospitals through the EDCD, Ministry of Health, 
and Government of Nepal. We strongly suggest improv-
ing and facilitating the diagnostic capacity for proper 
diagnosis and surveillance through well-equipped cen-
tres in the Terai region. This will contribute to identifying 
“hidden” viral pathogens as early as possible and, hence, 
may prevent the emergence of outbreaks. The Govern-
ment of Nepal, specifically the Ministry of Health, should 
prioritize appropriate staffing, equipping and training of 
medical facilities, including medical personnel at the pri-
mary health centre level and enable them to perform ini-
tial DENV diagnosis.
Conclusion
Efforts are needed in order to develop improved, proac-
tive, laboratory-based surveillance systems that can fore-
cast impending dengue epidemics in this country. This 
will help alert the public to take action and physicians to 
diagnose and properly treat DF/DHF/DSS cases in the 
Terai region. Strong coordination between the Ministry 
of Health, Government of Nepal, EDCD, Nepal Public 
Health Laboratory (NPHL) and local hospital laborato-
ries is necessary for dengue detection, confirmation and 
management. We do not think that current efforts are 
adequate for the diagnosis and management of dengue. 
Current capacities are limited to the stage of crisis man-
agement with rapid diagnostic kits. The implementation 
of systematic dengue surveillance including continuous 
laboratory supply for reliable diagnosis is needed to iden-
tify the real disease burden and to understand the geo-
graphical disease distribution.
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